![Marc Struhalla](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Marc Struhalla
Director Ejecutivo en c-LEcta GmbH .
Cargos activos de Marc Struhalla
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
c-LEcta GmbH
![]() c-LEcta GmbH BiotechnologyHealth Technology c-LEcta GmbH operates as a industrial biotechnology company that discovers, optimizes, produces, and sells enzymes for research, development, bio-catalysis, diagnostics, and industrial applications. The firm focuses on the utilization of proteins with catalytic properties. It offers recombinant RNases, exonucleases, alcohol-dehydrogenases, lipases, and proteases for applications in research and development; biocatalysts for the production of chemicals; and starch, cellulose, and hemicellulose hydrolyzing enzymes, as well as lipases and proteases to use as components in detergents and cleaning products for the food and feed industry. The company was founded by Marc Struhalla and Thomas Greiner-St?ffele in 2004 and is headquartered in Leipzig, Germany. | Director Ejecutivo | 01/01/2004 | - |
Fundador | 19/11/2009 | - | |
Director de Operaciones | 01/01/2004 | 24/06/2010 | |
Oficial de Recursos Humanos | 01/01/2004 | 24/06/2010 | |
Consejero General | 01/01/2004 | 24/06/2010 |
Historial de carrera de Marc Struhalla
Formación de Marc Struhalla.
Universität Leipzig | Undergraduate Degree |
University of Hamburg | Doctorate Degree |
Estadísticas
Internacional
Alemania | 4 |
Operativa
Chief Executive Officer | 1 |
Chief Operating Officer | 1 |
Founder | 1 |
Sectorial
Consumer Services | 3 |
Health Technology | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 1 |
---|---|
c-LEcta GmbH
![]() c-LEcta GmbH BiotechnologyHealth Technology c-LEcta GmbH operates as a industrial biotechnology company that discovers, optimizes, produces, and sells enzymes for research, development, bio-catalysis, diagnostics, and industrial applications. The firm focuses on the utilization of proteins with catalytic properties. It offers recombinant RNases, exonucleases, alcohol-dehydrogenases, lipases, and proteases for applications in research and development; biocatalysts for the production of chemicals; and starch, cellulose, and hemicellulose hydrolyzing enzymes, as well as lipases and proteases to use as components in detergents and cleaning products for the food and feed industry. The company was founded by Marc Struhalla and Thomas Greiner-St?ffele in 2004 and is headquartered in Leipzig, Germany. | Health Technology |
- Bolsa de valores
- Insiders
- Marc Struhalla
- Experiencia